Genetics-Driven Personalized Disease Progression Model
Not on the map. Why?
Abstract (arXiv)
Modeling disease progression through multiple stages is critical for clinical decision-making for chronic diseases, e.g., cancer, diabetes, chronic kidney diseases, and so on. Existing approaches often model the disease progression as a uniform trajectory pattern at the population level. However, chronic diseases are highly heterogeneous and often have multiple progression patterns depending on a patient's individual genetics and environmental effects due to lifestyles. We propose a personalized disease progression model to jointly learn the heterogeneous progression patterns and groups of genetic profiles. In particular, an end-to-end pipeline is designed to simultaneously infer the characteristics of patients from genetic markers using a variational autoencoder and how it drives the disease progressions using an RNN-based state-space model based on clinical observations. Our proposed model shows improvement on real-world and synthetic clinical data.
Key facts. No citing papers in the map yet (data through 7 Oct 2026). Builds on 6 of its 81 references that are in the map. First posted on arXiv 24 Feb 2025.
Builds on
6 of 81 references.
References · 6
- 2016Towards K-means-friendly Spaces: Simultaneous Deep Learning and Clusteringcited by 237
- 2016Structured Inference Networks for Nonlinear State Space Modelscited by 182
- 2021Integrating Expert ODEs into Neural ODEs: Pharmacology and Disease Progressioncited by 48
- 2016A Bayesian Nonparametric Approach for Estimating Individualized Treatment-Response Curvescited by 15
- 2016Localized Lasso for High-Dimensional Regressioncited by 11
- 2016Computational Drug Repositioning Using Continuous Self-controlled Case Seriescited by 1
Built on by
Not cited yet.